Treatment outcomes and spectral-domain optical coherence tomography findings of eyes with symptomatic vitreomacular adhesion treated with intravitreal ocriplasmin.
Phase of Trial: Phase IV
Latest Information Update: 10 Dec 2015
At a glance
- Drugs Ocriplasmin (Primary)
- Indications Retinal disorders
- Focus Therapeutic Use
- 10 Dec 2015 New trial record